A MULTICENTER, OPEN LABEL, UNCONTROLLED, PHASE II TRIAL EVALUATING SAFETY AND EFFICACY OF VENETOCLAX, ATEZOLIZUMAB ANDOBINUTUZUMAB IN RICHTER TRANSFORMATION FROM CLL

Authors :: Alessandra Tedeschi
Davide Rossi
Emanuele Zucca
Stefano Pileri
Franco Cavalli
Anna Maria Frustaci
Marco Montillo
Source :: Hematological Oncology. 37:557-558
Publication Year :: 2019
Publisher :: Wiley, 2019.

Subjects :: Oncology
Cancer Research
medicine.medical_specialty
Richter transformation
Venetoclax
business.industry
Hematology
General Medicine
chemistry.chemical_compound
chemistry
Atezolizumab
Internal medicine
medicine
Open label
business

Tools